Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelocytic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01167166
What this trial is testing

Safety and Efficacy of 72-hour and 120-hour Infusion of Rigosertib in Acute Myeloid Leukemia (AML) and Acute Lymphoid Leukemia (ALL)

Who this might be right for
Acute Myelocytic LeukemiaAcute Lymphocytic LeukemiaMyeloproliferative Disease+1 more
Traws Pharma, Inc. 30
Large-scale testing (Phase 3)Study completedNCT00962767
What this trial is testing

Comparison of Two Treatments in Intermediate and High-risk Acute Promyelocytic Leukemia (APL) Patients to Assess Efficacy in 1st Hematological Complete Remission and Molecular Remission

Who this might be right for
Leukemia, Myelocytic, Acute
Wyeth is now a wholly owned subsidiary of Pfizer 168
Early research (Phase 1)Ended earlyNCT02177812
What this trial is testing

A Phase I Dose Escalation Study of GSK2879552 in Subjects With Acute Myeloid Leukemia (AML)

Who this might be right for
Leukaemia, Myelocytic, Acute
GlaxoSmithKline 41
Large-scale testing (Phase 3)UnknownNCT00966810
What this trial is testing

Allogeneic Stem Cell Transplantation in CML With Partial T Cell Depletion

Who this might be right for
Philadelphia Chromosome-positive Chronic Myelocytic Leukemia
Rambam Health Care Campus 40
Testing effectiveness (Phase 2)Study completedNCT00811070
What this trial is testing

Study Evaluating SKI-606 (Bosutinib) In Japanese Subjects With Philadelphia Chromosome Positive Leukemias

Who this might be right for
Chronic Myelogenous Leukemia
Pfizer 63
Large-scale testing (Phase 3)Study completedNCT00044486
What this trial is testing

Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899)

Who this might be right for
Leukemia, Myelocytic, AcuteMyelodysplastic SyndromesNeutropenia
Merck Sharp & Dohme LLC 602
Testing effectiveness (Phase 2)Study completedNCT02158858
What this trial is testing

CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies

Who this might be right for
MyelofibrosisLeukemia, Myelocytic, AcuteMyelodysplastic/Myeloproliferative Neoplasm+11 more
Constellation Pharmaceuticals 336
Testing effectiveness (Phase 2)Ended earlyNCT00058747
What this trial is testing

AG-858 in Patients Who Are Cytogenetically Positive After Treatment With Gleevec™

Who this might be right for
Leukemia, Myeloid, Chronic
Agenus Inc. 40
Testing effectiveness (Phase 2)Study completedNCT01462578
What this trial is testing

Treatment of Patients With Myelodysplastic Syndrome or Acute Myelocytic Leukemia With an Impending Hematological Relapse With Azacitidine (Vidaza)

Who this might be right for
Acute Myelocytic LeukemiaMyelodysplastic Syndrome
Technische Universität Dresden 93
Testing effectiveness (Phase 2)Study completedNCT00628628
What this trial is testing

Rasburicase in Patients at Risk for Tumor Lysis Syndrome

Who this might be right for
Tumor Lysis Syndrome
M.D. Anderson Cancer Center 82
Not applicableUnknownNCT02975115
What this trial is testing

Evaluating True PCR-negative Rate of Frontline Dasatinib in Early Chronic Phase CML for Therapeutic Harmonization

Who this might be right for
Chronic Myelocytic Leukemia
Seoul St. Mary's Hospital 102
Not applicableStudy completedNCT00859586
What this trial is testing

Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphoblastic, AcuteLeukemia, Myelocytic, Chronic
National Heart, Lung, and Blood Institute (NHLBI) 8